Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0007097 (carcinoma)
 152,788 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

26 cases of malignant haemangioendothelioma (MHE) of the thyroid gland were investigated immunohistochemically with the endothelial marker UEA-1 lectin and the panepithelial marker Lu-5. The results were compared with the results of staining for factor VIII-related antigen in the same cases observed in a previous study of Pfaltz et al. The 26 cases were classified on light microscopic grounds without reference to the immunohistochemical results as classical MHE (15 cases) and borderline cases intermediate between MHE and undifferentiated carcinoma (11 cases). 7 of the 15 classical MHE revealed one or both of the vascular markers, but did not express the epithelial marker. One case showed no staining and another reacted only with Lu-5. Vascular and epithelial markers were found in 6 cases of the 15 classical MHE and in 2 of the 11 borderline cases. These findings indicate that MHE of the thyroid may represent a heterogeneous group of lesions. Tumours positive only for endothelial markers strongly support the hypothesis that MHE is of endothelial origin, whereas tumours which reacted only to the epithelial marker may be undifferentiated carcinomas. Cases with both epithelial and endothelial features on immunohistochemical investigation may represent either tumours in which the malignant cells are in transition from epithelial to mesenchymal differentiation as suggested by Eckert et al. or are tumours of malignant endothelial cells with epithelial differentiation particularly of their cytoskeleton.
 ...
PMID:Malignant haemangioendothelioma of the thyroid, immunohistochemical evidence of heterogeneity. 247 Nov 79

8 cases of branchial cleft cysts and 1 case of branchiogenic carcinoma were examined immunohistochemically for detectable keratin, immunoglobulins (IgG, IgA, IgM), carcinoembryonic antigen (CEA), factor VIII related antigen (Factor VIII RGA), and lysozyme. Lectin binding patterns were also determined. Histologically, cystic lining epithelia were classified into stratified squamous epithelium without keratinization, columnar epithelium with or without cilia, or a mixture of both. Almost all of the cases indicated accompanying lymphoid structures with germinal centers. Keratin expression in epithelial cells was slightly positive, and lectin binding affinities in them were similar to those of oral squamous epithelium. CEA was found on the surface border of columnar epithelial cells, but cystic epithelia in most of the cases were devoid of lysozyme. Endothelial cells of capillary vessels showed positive binding by UEA-1 lectin and the presence of factor VIII RAG. In the lymphoid structures, there were scattered strongly positive lysozyme-staining cells as well as a few lymphocytes bearing IgG, IgA, or IgM.
 ...
PMID:Branchial cleft cysts. Histologic and immunohistochemical aspects. 247 28

A 73-year-old woman with gallbladder carcinoma infiltrating to the liver presenting high serum values of AFP and CEA was reported. Serum values of AFP and CEA were remarkably high (165,000 ng/ml and 1,070 ng/ml). Immunohistochemically the tumor cells were stained for AFP and CEA by the PAP method. Serum AFP subfraction was analyzed by crossed immunoaffinoelectrophoresis with lentil lectin and concanavalin A, which showed most of the serum AFP bound to both lentil lectin and concanavalin A. As a case of gallbladder carcinoma presenting a high serum value of AFP is rare, it may imply a diagnostic challenge.
 ...
PMID:A case of gallbladder carcinoma producing both alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). 247 96

The coordinate increase in the hepatic production of the acute phase plasma proteins appears to be mediated by several cytokines produced by different cell types. One factor, hepatocyte-stimulating factor III (HSF-III), constitutively produced by human squamous carcinoma (COLO-16) cells, stimulates the synthesis of the same set of acute phase plasma proteins as the structurally distinct IL-6. The physicochemical properties of HSF-III coincide with those of the T cell-derived leukemia-inhibitory factor (LIF). Human rLIF, tested on hepatoma cells, indicated a liver-regulating activity identical to HSF-III. The LIF activity is specifically neutralized by HSF-III antibodies. COLO-16 cells contain an LIF mRNA which is characteristic for lectin-stimulated T cells, suggesting that HSF-III is an epidermal cell-derived form of LIF. This result provides additional evidence for the close relationship between acute phase regulation of the liver and control of proliferation and differentiation of hemopoietic cells by identical cytokines.
 ...
PMID:Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. 247 20

The receptors of peanut agglutinin (PNA), Dolichos biflorus agglutinin (DBA) and Ulex europaeus agglutinin I (UEA-I) were localized in intrahepatic cholangiocellular carcinoma, hepatocellular carcinoma, intrahepatic bile ducts and normal, cirrhotic and pericarcinomatous liver using the avidin-biotin-peroxidase complex method. It was found that epithelial cells of normal bile ducts had many UEA-I receptors, fewer DBA receptors and no PNA receptors. The positive rates of PNA, UEA-I and DBA receptors in 18 cases of intrahepatic cholangiocellular carcinoma were 88.9%, 61.1% and 33.3% respectively, which were significantly higher than those in hepatocellular carcinoma (16.0%, 4.0% and 4.0% respectively). Hepatocytes in normal, cirrhotic and pericarcinomatous liver had no receptors for these three lectins. It is suggested that lectin receptor distribution in intrahepatic cholangiocellular carcinoma is obviously different from that in normal bile duct cells and in hepatocellular carcinoma, and might be used as an auxiliary index in its clinical diagnosis.
 ...
PMID:Characteristics of the distribution of lectin receptors in intrahepatic cholangiocellular carcinoma. 247 21

Twenty cases of intrahepatic cholangiocellular carcinoma (IHCCC) were studied by lectin histochemistry for their glycoconjugate expression. Combined alcian blue-peroxidic acid Schiff (ABPS) staining was also made for mucins in these tissues. Results showed that epithelial cells of intrahepatic bile ducts contained varied quantity of DBA, WGA, LCA, Con A, PHA, RCAI, BLAI, SJA, SBA, PSA and UEAI receptors but no PNA receptors. Lectin receptors were present at varying rates; 100% (Con A), 95% (PSA), 90% (LCA), 95% (WGA), 30% (BSAI), 35% (DBA), 65% (PHA), 74% (PNA), 85% (RCAI), 35% (SBA), 25% (SJA) and 55% (UEAI), respectively. The positive rates in well-differentiated IHCCC were significantly higher than those in either moderately or poorly-differentiated IHCCC. The distribution of lectin receptors in IHCCC was obviously different from that in peri-carcinomatous, cirrhotic and normal liver, and also differed from that in epithelial cells of normal intrahepatic bile ducts. All larger ducts were stained by ABPS and were mainly blue colour, while only 80% of IHCCC were positive for ABPS staining. Most of them were blue, others were red or purple. The results suggest that the expression of glycoconjugates had changed after the neoplastic transformation of bile duct cells.
 ...
PMID:Expression of glycoconjugates in intrahepatic cholangiocellular carcinoma. 247 43

We report a case of primary epithelioid hemangioendothelioma of the liver occurring in a patient with primary biliary cirrhosis, stage III. The hepatic tumor was found incidentally by imaging techniques and was surgically resected under a tentative diagnosis of metastatic carcinoma. The resected tumor (1.8 x 1.6 cm) showed typical histologic features of epithelioid hemangioendothelioma. The tumor cells were positive for factor VIII-related antigen and were stained with Ulex europaeus lectin I. Ultrastructurally, the tumor cells showed cytoplasmic vacuoles, tight junctions, basal lamina, pinocytotic vesicles, bundles of thin filaments (approximately 10 nm in diameter) and Weibel-Palade bodies. The non-tumorous part of the liver showed features of primary biliary cirrhosis, stage III. This is the first reported case of epithelioid hemangioendothelioma occurring in a liver with primary biliary cirrhosis.
 ...
PMID:Epithelioid hemangioendothelioma of the liver in primary biliary cirrhosis. A case report. 248 Jun 95

A growth-inhibitory (GI) factor, that specifically inhibits the growth of mouse monocytic leukemia cells, was found in conditioned medium of mouse lung tissue, but not in that of mouse brain, heart, liver, or kidney tissue. Conditioned medium of spleen or bone marrow cells had low GI activity. Pulmonary macrophages were as active as peritoneal and bone-marrow-derived macrophages in production of the GI activity. The GI factor inhibited the growth of murine monocytic leukemia cell lines Mm-A and J774.1, but scarcely inhibited the growth of other mouse cell lines, such as a myeloblastic leukemia cell line (M1), a Friend erythroleukemia cell line (745A) and a mammary carcinoma cell line (FM3A). It had no significant effect on the growth of human monocytic leukemia cell lines U937 and THP-1 or on the HL-60 promyelocytic leukemia cell line. These results suggest that the GI factor produced by mouse lung tissue preferentially inhibits the growth of mouse monocytic cells. The GI factor was found to be a proteinaceous substance with a molecular mass of 25 kDa. On chromatofocusing, the GI activity was eluted with Polybuffer 96/acetic acid at pH 7.2-7.5. The GI activity was not significantly decreased by heat treatment at 56 degrees C for 30 min or acid treatment (0.01 M HCl, 14 h), but the GI activity in glycosidase-treated conditioned medium of lung tissue was lost on heat treatment. The GI activity could not be neutralized with anti-(interferon alpha + beta) antibody. The activity was produced constitutively by lung tissues and its production was not stimulated appreciably by lipopolysaccharide, lectin, or poly(I).poly(C). The GI factor appears to be a cytokine unrelated to known cytokines such as tumor necrosis factor, interleukin-1, transforming growth factor beta, and interferons. These results suggest that the GI factor may be involved in negative feedback regulation of macrophage production in steady-state conditions in the lungs.
 ...
PMID:Normal mouse lung tissue produces a growth-inhibitory factor(s) preferential for mouse monocytic leukemia cells. 248 Aug 47

In order to establish a useful and objective marker of malignancy of oral mucosa, the binding sites for Ulex europaeus agglutinin I (UEA-I). Bandeiraea simplicifolia agglutinin I (BSA-I) and peanut agglutinin (PNA) were comparatively examined in the surgical materials from the normal, dysplastic and cancerous epithelium of the oral mucosa by a novel lectin-antilectin immunoperoxidase method. Based on the staining patterns of the normal keratinized epithelium, UEA-I was regarded as the marker for the prickle cells, BSA-I for the cells in the upper prickle to the horny layers, and PNA for those in the basal layer. As the degree of dysplasia advanced, all layers of epithelium came to react with UEA-I and PNA, whereas the BSA-I binding was negative. Positive reactions for UEA-I and PNA were seen in most carcinoma cells other than the keratinizing foci stained by BSA-I. The results indicate that a UEA-I-positive reaction in the basal cells, a PNA-positive in the prickle cells and loss of receptor for BSA-I occur in the course of malignant transformation of oral mucosa, and that these lectins may be regarded as useful markers of oral epithelial cytoplasmic differentiation.
 ...
PMID:Differential lectin-bindings in normal and precancerous epithelium and squamous cell carcinoma of the oral mucosa. 248 35

In recent years histochemical methods using lectins with diverse carbohydrate binding specificities have proved useful tools for studying the distribution pattern of intracellular and pericellular glycoconjugates at the tissue level. Several studies of human kidneys have shown that the binding sites for certain lectins are strictly confined to various parts of the nephron. This allows the use of lectins as markers for the particular segments. The glomeruli exhibit abundant sialoglycoproteins at the free surface coat of the podocytes as detected by PNA after sialidase representing a major component of the filtration barrier; neoplastic podocytes of glomeruloid bodies in nephroblastomas as well revealed an intense lectin binding despite failing any vascularization. The lectin binding pattern of renal carcinomas varies within a wide range depending on their histological growth pattern. Whereas most renal carcinomas of clear and granular cell type rarely displayed a slight reactivity with lectins at the cell surface and at the luminal aspect of tubulopapillary tumors, a sub-group of carcinomas named chromophobe type exhibited a strong cytoplasmic staining with DBA and PNA after sialidase. Comparative evaluation of normal kidneys revealed an identical binding pattern exclusively in the intercalated cells of the collecting ducts probably indicating a histogenetic origin of these tumors from the collecting duct epithelium. This assumption derives further support from the detection of precursor lesions rarely detected in normal and tumor-bearing kidneys exhibiting the same lectin binding pattern. In accordance with recent observations in the literature the disclosure of a similar lectin binding pattern in renal oncocytomas and their precursor lesions exhibiting oncocytic transformation clearly favors the assumption of an identical histogenetic origin. On the other hand, few cases of a carcinoma mimicking collecting duct epithelium exhibited a broader lectin binding pattern revealing evidence of secretory activity; the histochemical similarities between this unusual carcinoma and transitional cell carcinoma confirmed the suggested origin from the ducts of Bellini. In conclusion, lectin histochemistry may be a useful tool for estimating the characteristics of renal tumors and elucidating their histogenesis.
 ...
PMID:[Lectin histochemistry in the kidney and renal tumors]. 248 19


<< Previous 1 2 3 4 5 6 7 8 9 10